Found 143 clinical trials
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial fibrillation (AF). In this particular setting, balancing between the prevention of thrombosis and the risk of bleeding remains challenging. Oral anticoagulation (OAC) prevents stroke and …
- 0 views
- 12 Nov, 2021
- 1 location
DyeVert System and Contrast-induced Acute Kidney Injury (REMEDIALIV)
The aim of the REnal Insufficiency Following Contrast MEDIA Administration TriaL IV (REMEDIAL IV) is to test whether the use of the DyeVert system is effective in reducing CI-AKI rate in ACS patients undergoing urgent/immediate (within 2 hours) invasive diagnostic and/or interventional cardiovascular procedures. The DyeVert™ system (Osprey Medical Inc., …
- 0 views
- 26 Mar, 2022
- 1 location
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome (ANDAMAN)
To compare treatment with Aspirin Protect twice a day (100 mg in the morning and 100 mg in the evening) versus Aspirin Protect 100 mg once per day on a composite end-point of ischemic events in diabetic patients, or in patients with a known risk factor for non-optimal aspirin response …
- 0 views
- 25 Jan, 2022
- 1 location
CRP Apheresis in STEMI
Background: In patients with acute ST-elevation myocardial infarction (STEMI), the amount of infarcted myocardium (infarct size) is known to be a major predictor for adverse remodeling and
- 0 views
- 02 Jul, 2021
- 4 locations
Multicenter Cohort of STEMI Patients (HIBISCUS-STEMI)
, treatment response and prognosis after acute myocardial infarction. Secondary objectives of the HIBISCUS-STEMI cohort to establish a clinical database, completed by biological samples and by imaging
- 0 views
- 24 Feb, 2022
- 3 locations
Adjunctive, Low-dose tPA in Primary PCI for STEMI (STRIVE)
infarction (STEMI) in reducing the incidence of post-procedural myocardial blush (MBG) grade 0/1 or distal embolization.
- 22 views
- 01 Mar, 2022
- 1 location
Deferred Stenting in Patients With Anterior Wall STEMI (INNOVATIONCORE)
>(INNOVATION-CORE) Objectives) To evaluate the impact of deferred versus immediate stenting in patients with acute ST-segment elevation anterior wall myocardial infarction (STEMI) on
- 6 views
- 01 Feb, 2022
- 1 location
Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT)
Left ventricular thrombus is a common complication subsequent to ST-segment elevation myocardial infarction (STEMI) that related to increased embolic events. This study aims to assess the
- 0 views
- 01 Mar, 2022
- 1 location
Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients
) treatment could decrease the myocardial infarct size in STEMI patients and improve clinical outcomes.
- 0 views
- 28 Jan, 2021
- 1 location
Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI
Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction
- 0 views
- 24 Mar, 2022
- 1 location